Table 2.
Prognostic significance of inflammation parameters for the overall survival of surgically resectable ovarian cancer.
| Variables | Univariate | Multivariate | ||||
|---|---|---|---|---|---|---|
| HR | 95% CI | P value | HR | 95% CI | P value | |
| Age (>55 vs.≤55) | 1.242 | 1.008-1.530 | 0.042 | 0.956 | 0.686-1.332 | 0.791 |
| Menopause (No vs. Yes) | 1.336 | 1.079-1.655 | 0.008 | 1.373 | 0.979-1.925 | 0.066 |
| FIGO stage | ||||||
| I | 0.426 | 0.210-0.867 | 0.019 | 0.449 | 0.219-0.917 | 0.028 |
| II | 0.528 | 0.317-0.880 | 0.014 | 0.573 | 0.343-0.959 | 0.034 |
| III | 1.074 | 0.796-1.450 | 0.640 | 1.029 | 0.760-1.392 | 0.856 |
| IV | 1.000 | 1.000 | ||||
| Family history of cancer (No vs. Yes) | 0.909 | 0.727-1.137 | 0.404 | |||
| Residual disease (>1cm vs. ≤1cm) | 1.584 | 1.224-2.050 | <0.001 | 1.386 | 1.066-1.802 | 0.015 |
| Histology (Other vs. Serous) | 1.113 | 0.846-1.465 | 0.443 | |||
| Grade | ||||||
| Well | 0.862 | 0.627-1.185 | 0.360 | |||
| Moderate | 1.088 | 0.848-1.396 | 0.506 | |||
| Poor | 1.000 | |||||
| Lymph node status (Negative vs. Positive) | 1.184 | 0.959-1.462 | 0.116 | |||
| CA125 at diagnosis (>35 U/ml vs.≤35 U/ml) | 1.389 | 0.781-2.470 | 0.264 | |||
| NLR (≥2.87 vs.<2.87) | 1.195 | 0.968-1.476 | 0.098 | |||
| LMR (≥2.73 vs.<2.73) | 0.817 | 0.663-1.006 | 0.057 | |||
| PLR (≥182.23 vs.<182.23) | 1.235 | 1.002-1.522 | 0.047 | 1.158 | 0.935-1.434 | 0.179 |
| SII (≥727.90 vs.<727.90) | 1.214 | 0.983-1.499 | 0.072 | |||
| PNR(≥24.65 vs.<24.65) | 1.320 | 0.963-1.810 | 0.085 | |||
The bold values represent P<0.05.